Cargando…

New participant stratification and combination of urinary biomarkers and confounders could improve diagnostic accuracy for overactive bladder

Overactive bladder (OAB) is a highly prevalent symptom complex characterised by symptoms of urinary urgency, increased frequency, nocturia, with or without urge incontinence; in the absence of proven infection or other obvious pathology. The underlying pathophysiology of idiopathic OAB is not clearl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Firouzmand, Sepinoud, Ajori, Ladan, Young, John S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033236/ https://www.ncbi.nlm.nih.gov/pubmed/32080289 http://dx.doi.org/10.1038/s41598-020-59973-6

Ejemplares similares

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Urinary beta 3-adrenoceptor as a diagnostic biomarker for overactive bladder in women
por: Liang, Ching-Chung, et al.
Publicado: (2023)

Evolutionary, ecological and biotechnological perspectives on plasmids resident in the human gut mobile metagenome
por: Ogilvie, Lesley A., et al.
Publicado: (2012)

Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?
por: Shim, Ji Sung, et al.
Publicado: (2016)

Urinary ATP May Be a Dynamic Biomarker of Detrusor Overactivity in Women with Overactive Bladder Syndrome
por: Silva-Ramos, Miguel, et al.
Publicado: (2013)

Could urinary nerve growth factor and bladder wall thickness predict the treatment outcome of children with overactive bladder?
por: Huseynov, Adil, et al.
Publicado: (2022)

AB206. Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis
por: Qu, HC, et al.
Publicado: (2014)

Fesoterodine for the treatment of urinary incontinence and overactive bladder
por: Ellsworth, Pamela
Publicado: (2009)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
por: Heesakkers, John P. F. A., et al.
Publicado: (2011)

Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder
por: Farhan, Bilal, et al.
Publicado: (2019)

Urinary Microbiome and Psychological Factors in Women with Overactive Bladder
por: Wu, Peng, et al.
Publicado: (2017)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients
por: Suh, Yoon Seok, et al.
Publicado: (2017)

Toileting behaviors, urinary cues, overactive bladder, and urinary incontinence in older women
por: O’Connell, Kathleen A., et al.
Publicado: (2022)

Socioeconomic Costs of Overactive Bladder and Stress Urinary Incontinence in Korea
por: Sung, Wooseuk, et al.
Publicado: (2012)

The Association Between Urinary Tract Infection and Overactive Bladder Treatment
por: Liao, Kuang-Ming, et al.
Publicado: (2022)

Urinary Tract Infection in Overactive Bladder: An Update on Pathophysiological Mechanisms
por: Mansfield, Kylie J., et al.
Publicado: (2022)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Urinary brain-derived neurotrophic factor and nerve growth factor as noninvasive biomarkers of overactive bladder in children
por: Colic, Merima, et al.
Publicado: (2022)

Current role of treatment in men with lower urinary tract symptoms combined with overactive bladder
por: Lee, Seung Hwan, et al.
Publicado: (2014)

Association of Urinary Urgency and Delay Time of Micturition in Women With Overactive Bladder
por: Park, Kyung Kgi, et al.
Publicado: (2014)

Urodynamic characteristics of lower urinary tract of patients with idiopathic overactive bladder
por: Dekhtiar, Yuriy M., et al.
Publicado: (2019)

Female Functional Constipation Is Associated with Overactive Bladder Symptoms and Urinary Incontinence
por: Maeda, Takahiro, et al.
Publicado: (2017)

Recurrent urinary tract infection in women and overactive bladder – Is there a relationship?
por: Ke, Qian-Sheng, et al.
Publicado: (2020)

AB195. Correlations among improvements in overactive bladder symptom scores (OABSS) and urinary nerve growth factor levels in overactive bladder patients
por: Yang, Bo
Publicado: (2016)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer
por: Sun, Liping, et al.
Publicado: (2017)

Biomarkers in Overactive Bladder: A New Objective and Noninvasive Tool?
por: Antunes-Lopes, Tiago, et al.
Publicado: (2011)

Adaptive changes of telocytes in the urinary bladder of patients affected by neurogenic detrusor overactivity
por: Traini, Chiara, et al.
Publicado: (2017)

Quantitative Changes in Cerebral Perfusion during Urinary Urgency in Women with Overactive Bladder
por: Arya, Nisha G., et al.
Publicado: (2017)

The effect of vitamin D deficiency in children with overactive bladder related urinary incontinence
por: Özçift, Burak, et al.
Publicado: (2022)

Potential Biomarkers for Diagnosis of Overactive Bladder Patients: Urinary Nerve Growth Factor, Prostaglandin E2, and Adenosine Triphosphate
por: Suh, Yoon Seok, et al.
Publicado: (2017)

Role of KIT-Positive Interstitial Cells of Cajal in the Urinary Bladder and Possible Therapeutic Target for Overactive Bladder
por: Kubota, Yasue, et al.
Publicado: (2011)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Review of the epidemiology of overactive bladder
por: Eapen, Renu S, et al.
Publicado: (2016)

Impact of depression on overactive bladder
por: Kawahara, Takashi, et al.
Publicado: (2020)

Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j4iaon6vjetb088fe0kaa9og1h